Cargando…

Therapeutic utility of palmitoylethanolamide in the treatment of neuropathic pain associated with various pathological conditions: a case series

Palmitoylethanolamide (PEA), an endogenous fatty acid amide, has been demonstrated to bind to a receptor in the cell nucleus – the peroxisome proliferator–activated receptor – and performs a great variety of biological functions related to chronic and neuropathic pain and inflammation, as has been d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hesselink, Jan M Keppel, Hekker, Thecla AM
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2012
Materias:	Case Series
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3500919/ https://www.ncbi.nlm.nih.gov/pubmed/23166447 http://dx.doi.org/10.2147/JPR.S32143

Ejemplares similares

Chronic idiopathic axonal neuropathy and pain, treated with the endogenous lipid mediator palmitoylethanolamide: a case collection
por: Hesselink, J M Keppel
Publicado: (2013)

Topical phenytoin for the treatment of neuropathic pain
por: Kopsky, David J, et al.
Publicado: (2017)

Phenytoin Cream for the Treatment of Neuropathic Pain: Case Series
por: Kopsky, David J., et al.
Publicado: (2018)

Palmitoylethanolamide, a neutraceutical, in nerve compression syndromes: efficacy and safety in sciatic pain and carpal tunnel syndrome
por: Keppel Hesselink, Jan M, et al.
Publicado: (2015)

Treatment of chronic regional pain syndrome type 1 with palmitoylethanolamide and topical ketamine cream: modulation of nonneuronal cells
por: Keppel Hesselink, Jan M, et al.
Publicado: (2013)

Effect of palmitoylethanolamide on inflammatory and neuropathic pain in rats
por: Seol, Tai-Kyung, et al.
Publicado: (2017)

Evolution in pharmacologic thinking around the natural analgesic palmitoylethanolamide: from nonspecific resistance to PPAR-α agonist and effective nutraceutical
por: Hesselink, Jan M Keppel
Publicado: (2013)

Palmitoylethanolamide, a Natural Retinoprotectant: Its Putative Relevance for the Treatment of Glaucoma and Diabetic Retinopathy
por: Keppel Hesselink, Jan M., et al.
Publicado: (2015)

Short-Term Efficacy of Ultramicronized Palmitoylethanolamide in Peripheral Neuropathic Pain
por: Cocito, Dario, et al.
Publicado: (2014)

Micronized Palmitoylethanolamide Reduces the Symptoms of Neuropathic Pain in Diabetic Patients
por: Schifilliti, Chiara, et al.
Publicado: (2014)

Walking with Neuropathic Pain: Paradoxical Shift from Burden to Support?
por: Kopsky, David J., et al.
Publicado: (2015)

EMA401: an old antagonist of the AT2R for a new indication in neuropathic pain
por: Keppel Hesselink, Jan M, et al.
Publicado: (2017)

Comment on “Short-Term Efficacy of Ultramicronized Palmitoylethanolamide in Peripheral Neuropathic Pain”
por: Kriek, R.
Publicado: (2014)

ALIAmides Update: Palmitoylethanolamide and Its Formulations on Management of Peripheral Neuropathic Pain
por: D’Amico, Ramona, et al.
Publicado: (2020)

Single-Blind Placebo-Controlled Response Test with Phenytoin 10% Cream in Neuropathic Pain Patients
por: Kopsky, David J., et al.
Publicado: (2018)

Central Neuropathic Pain in a Patient with Multiple Sclerosis Treated Successfully with Topical Amitriptyline
por: Kopsky, David J., et al.
Publicado: (2012)

Neuropathic Corneal Pain Following LASIK Surgery: A Retrospective Case Series
por: Moshirfar, Majid, et al.
Publicado: (2021)

Reduction of painful area as new possible therapeutic target in post-herpetic neuropathic pain treated with 5% lidocaine medicated plaster: a case series
por: Casale, Roberto, et al.
Publicado: (2014)

Palmitoylethanolamide: A Natural Body-Own Anti-Inflammatory Agent, Effective and Safe against Influenza and Common Cold
por: Keppel Hesselink, J. M., et al.
Publicado: (2013)

Multimodal Stepped Care Approach Involving Topical Analgesics for Severe Intractable Neuropathic Pain in CRPS Type 1: A Case Report
por: Kopsky, David J., et al.
Publicado: (2011)

Topical loperamide for the treatment of localized neuropathic pain: a case report and literature review
por: Kopsky, DJ, et al.
Publicado: (2019)

Intrathecal Ziconotide and Morphine for Pain Relief: A Case Series of Eight Patients with Refractory Cancer Pain, Including Five Cases of Neuropathic Pain
por: de la Calle Gil, Ana Bella, et al.
Publicado: (2015)

Can treatment success with 5% lidocaine medicated plaster be predicted in cancer pain with neuropathic components or trigeminal neuropathic pain?
por: Kern, Kai-Uwe, et al.
Publicado: (2013)

Neuropathic itch treated with oral cannabinoids: A case series
por: Morin, Catherine Besner, et al.
Publicado: (2021)

Ethical justification of single-blind and double-blind placebo-controlled response tests in neuropathic pain and N-of-1 treatment paradigm in clinical settings
por: Keppel Hesselink, Jan M, et al.
Publicado: (2019)

The Beneficial Effects of Ultramicronized Palmitoylethanolamide in the Management of Neuropathic Pain and Associated Mood Disorders Induced by Paclitaxel in Mice
por: Cristiano, Claudia, et al.
Publicado: (2022)

Effects of Palmitoylethanolamide (PEA) on Nociceptive, Musculoskeletal and Neuropathic Pain: Systematic Review and Meta-Analysis of Clinical Evidence
por: Scuteri, Damiana, et al.
Publicado: (2022)

Capsaicin 8% patch as therapy for neuropathic chronic postsurgical pain after melanoma excision surgery: A single center case series
por: Laude-Pagniez, Eulalie, et al.
Publicado: (2022)

Palmitoylethanolamide reduces pain-related behaviors and restores glutamatergic synapses homeostasis in the medial prefrontal cortex of neuropathic mice
por: Guida, F., et al.
Publicado: (2015)

A randomized controlled trial assessing the safety and efficacy of palmitoylethanolamide for treating diabetic-related peripheral neuropathic pain
por: Pickering, Emily, et al.
Publicado: (2022)

Novel Approach to the Treatment of Neuropathic Pain Using a Combination with Palmitoylethanolamide and Equisetum arvense L. in an In Vitro Study
por: Ruga, Sara, et al.
Publicado: (2023)

Pathological Mechanisms and Therapeutic Targets for Trigeminal Neuropathic Pain
por: Bista, Pawan, et al.
Publicado: (2019)

Metabotropic Glutamate Receptor 5 and 8 Modulate the Ameliorative Effect of Ultramicronized Palmitoylethanolamide on Cognitive Decline Associated with Neuropathic Pain
por: Boccella, Serena, et al.
Publicado: (2019)

Immediate Effect of Therapeutic Massage on Pain Sensation and Unpleasantness: A Consecutive Case Series
por: Menard, Martha Brown
Publicado: (2015)

Treatment of localized neuropathic pain after disk herniation with 5% lidocaine medicated plaster
por: Likar, Rudolf, et al.
Publicado: (2012)

Treatment of localized post-traumatic neuropathic pain in scars with 5% lidocaine medicated plaster
por: Correa-Illanes, Gerardo, et al.
Publicado: (2010)

Palmitoylethanolamide for the treatment of pain: pharmacokinetics, safety and efficacy
por: Gabrielsson, Linda, et al.
Publicado: (2016)

Various radiological findings in patients with COVID-19: A case series
por: Riawati, Theresia, et al.
Publicado: (2021)

Use of low intensity laser treatment in neuropathic pain refractory to clinical treatment in amputation stumps
por: Ribas, Eduardo Santamaria Carvalhal, et al.
Publicado: (2012)

Long-term administration of high doses of transdermal buprenorphine in cancer patients with severe neuropathic pain
por: Leppert, Wojciech, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_lomrmcipi9ki5m44qn4i628aub